Anorexia
Reference List

1. Anderson, K. N. (Ed.) (1994). Mosby's medical, nursing and allied health dictionary (4th ed.). St. Louis, MO: Mosby.
2. Barber, M.D., Fearon, K.C.H., Tisdale, M.J., McMillan, D.C., Ross, J. A. (2001). Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutrition and Cancer, 40, 118-24.
3. Berendt, M. (1998). Alterations in nutrition. Itano, J.K. & Taoka, K.N. (Eds.) Core curriculum for oncology nursing, (3rd ed., pp. 223-258). Philadelphia: W. B. Saunders Company.
4. Brown, J.K. (2002). A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncology Nursing Forum, 29, 517-531.
5. Bruera, E. & MacDonald, R.N. (1998). Nutrition in cancer patients: an update and review of our experience. Journal of Pain Symptom Management, 3, 133-140.
6. Cope, D. (2002). Management of anorexia, cachexia, and weight loss in patients with advanced cancer. Clinical Journal of Oncology Nursing, 40, 241-42.
7. Davis, Mellar P. (2002). New drugs for the Anorexia-Cachexia Syndrome, Current Oncology Reports 2002, 4:268.
8. Deglin, J.H., & Vallerand, A.H. (1997). Davis's drug guide for nurses, (5th ed.). Philadelphia: F. A. Davis Company.


9. Dell, D. (2002). Cachexia in patients with advanced cancer. Clinical Journal of Oncology Nursing, 6, 235-38.
10. DeWys, W. (1972). Anorexia as a general effect of cancer. Cancer, 45, 2013-2019.
11. Dodd, M.J. (2001). Chemotherapy and radiation therapy (pp. 131-135 & 248-252). School of Nursing, University of California, San Francisco: UCSF Nursing Press.
12. Downer, S., Joel, S., Albright, A. et al. (1993). A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia. British Journal of Cancer, 67, 1102-1105.
13. Foltz, A.T. (2000). Nutritional disturbances. In C.H. Yarbro, M.H. Fogge, M. Goodman & S.I. Groenwald (Eds.), Cancer nursing principles and practice (5th ed., pp. 745-775). Boston: Jones and Bartlett.
14. Gagnon B., & Bruera, E. (1998). A review of the drug treatment of cachexia associated with cancer. Drugs, 55, 675-688.
15. Hawkins, C. (2002). Anorexia and anxiety in advanced malignancy: The relative problem. J Hum Nutr Dietet, 13, 113-117.
16. Hoffman, B. (1996). A cancer survivor's almanac:charting your journey (pp.15-16). Minneapolis, MN: Chronimed Publishing.
17. Jatoi, A. & Loprinzi, C.L. (2001). Current management of cancer-associated anorexia and weight loss. Oncology, 15, 497-508.
18. Langhans, Wolfgang (2002) Neurochemical Mechanisms for Cancer Anorexia, Nutrition 18:100.
19. Lees, J. (1999). Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. European Journal of Cancer Care, 8, 133-136.
20. Lopez, M.J., & Tehrani, H.Y. (2001). Nutrition and the cancer patient. In R.E. Lenhard, R.T. Osteen, & T. Gansler (Eds.) Clinical oncology (pp. 811-822). Atlanta: American Cancer Society.
21. Loprinkzi, C., & Aminah, J. (2001). Current management of cancer-associated anorexia and weight loss. Oncology, 15, 497-508.
22. Marchesini, Giulio; Bianchi, Giampaolo; Lucidi, Paola; Villanova, Nicola; Zoll, Marco; and DeFeo, Pierpaola (2004). Plasma Ghrelin Concentration, Food Intake and Anorexia in Liver Failure, the Journal of Clinical Endocrinology & Metabolism, 89(5): 2136.
23. McMillian, D.C., Wilgmore, S.J., Fearon, K.C.H, O'Gorman, P., Wright, C.E., & McArdle, C.S. (1999). A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. British Journal of Cancer, 79(3/4), 495-500.
24. Medscape (2002). Advances in the management of tumor-induced weight loss. Retrieved September 10, 2002, from http://www.medscape.com/viewprogram/2008.
25. Nelson, K. A. (2000). The cancer anorexia-cachexia syndrome. Seminars in Oncology, 27, 64-68.
26. Ottery, F.D. (1995). Supportive nutrition to prevent cachexia and improve quality of life. Seminars in Oncology, 22(2 Suppl.3), 98-111.
27. Palesty, J.A. and Dudrick, S.J. (2003). What we have learned about cachexia in Gastrointestinal Cancer, Digestive Diseases, 2003; 21:206.
28. Pharmacologic Approaches (2002). Advances in the management of tumor-induced weight loss. Retrieved September 10, 2002, from http://www.medscape.com/viewprogram/2008, section 5 of 15.
29. Puccio, M., & Nathanson, L. (1997). The cancer cachexia syndrome. Seminars in Oncology, 24, 277-287.
30. Schimmer, B. P., & Parker, K. L. (1996). Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th ed.) (pp. 1459-1485). New York: McGraw-Hill.
31. Simons, J., Aaronson, N. K., Vansteenkiste, J. F., et al. (1996). Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: A placebo-controlled multicenter study. Clinical Journal of Oncology, 14, 1077-1084.
32. Smith, J.S., & Souba, W.W. (2001). Nutritional Support. In D. T. DeVita, Jr., S. Hellman, & S. A. Rosenber (Eds.) Cancer, principles and practice of oncology (pp. 3012-3032). Philadelphia: Lippincott, Williams & Wilkins.
33. Stepp, L., & Parkiz, T. (2001). Anorexia and cachexia in advanced cancer. Nursing Clinics of North America, 36, 735-743.
34. Thomas, C. L. (Ed.) (1997). Taber's cyclopedic medical dictionary, (18th ed.). Philadelphia: A. A. Davis Company.
35. Treatment of TIWL, Pharmacologic approaches. Advances in the management of tumor-induced weight loss. Retrieved September 10, 2002 from http://www.medscape.com/viewprogram/2008.
36. Wilkes, G.M., & Yemma, T. (1997). Nutritional Support. In C. Varricchio (Ed.), A cancer source book for nurses (7th ed), (pp. 200-213). Atlanta: American Cancer Society.
37. Whitman, M. (2000). The starving patient: Supportive care for people with cancer. Clinical Journal of Oncology Nursing, 4, 121-125.